StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Northwest Biotherapeutics's price to sales ratio was 119.2× on Oct 19, 2026, against 330.0× a year earlier. Over the last 5 years it ranged from 0.0× to 483.6×, with a median of 255.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 2026119.2×−251.5
2025Dec 31, 2025370.7×+149.2
2024Dec 31, 2024221.4×−163.2
2023Dec 29, 2023384.6×+384.6
2022Dec 30, 20220.0×−483.6
2021Dec 31, 2021483.6×+94.8
2020Oct 30, 2020388.8×+246.3
2019Jan 31, 2019142.5×+22.8
2018Dec 31, 2018119.7×+0.4
2017Dec 29, 2017119.3×+89.4
2016Dec 30, 201629.9×−113.2
2015Dec 31, 2015143.1×−344.7
2014May 30, 2014487.8×+308.9
2013Dec 31, 2013178.9×+178.8
2012Dec 31, 20120.1×−3.4
2011Dec 30, 20113.5×–

More Northwest Biotherapeutics figures

See a number that looks wrong?